A Senate hearing scheduled for Dec. 4 will address electronic prescribing for controlled substances that are currently banned from e-prescribing by the Drug Enforcement Agency. Proponents of e-prescribing for these drugs note that the current rules hinder e-prescribing for all drugs because doctors often handwrite all scripts instead of maintaining separate systems for controlled and noncontrolled therapies.

Related Summaries